Ginger Smith-Swintosky is the Mental Health Global Program Leader for Johnson & Johnson Global Public Health. She leads a matrix team accountable for defining and recommending an overarching strategy and aspiration for a global interventional program in mental health in resource limited settings addressable by J&J products, capabilities and technologies. She currently leads a project focused on partnering with local stakeholders to develop a sustainable quality care model for people living with schizophrenia in Rwanda.
Ginger is a neurobiologist with 20 years of experience in pharmaceutical R&D and business development. Prior to joining J&J GPH, she held leadership positions in drug discovery, early clinical research and corporate business development. Ginger received her Ph.D. in Biopsychology (Neuroscience) from the University of Delaware and completed post-doctoral studies at the Sanders-Brown Research Center on Aging and the Department of Anatomy and Neurobiology at the University of Kentucky Chandler Medical Center.
Date: 27 March 2018